Quest Diagnostics Inc (DGX)
135.45
-2.10
(-1.53%)
USD |
NYSE |
Apr 25, 16:00
135.45
0.00 (0.00%)
After-Hours: 16:30
Quest Diagnostics Cash from Financing (TTM): 160.00M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 160.00M |
September 30, 2023 | -515.00M |
June 30, 2023 | -906.00M |
March 31, 2023 | -1.337B |
December 31, 2022 | -1.732B |
September 30, 2022 | -1.556B |
June 30, 2022 | -1.12B |
March 31, 2022 | -2.445B |
December 31, 2021 | -2.54B |
September 30, 2021 | -2.991B |
June 30, 2021 | -3.005B |
March 31, 2021 | -942.00M |
December 31, 2020 | -1.267B |
September 30, 2020 | 63.00M |
June 30, 2020 | 86.00M |
March 31, 2020 | -830.00M |
December 31, 2019 | 225.00M |
September 30, 2019 | -362.00M |
June 30, 2019 | -479.00M |
March 31, 2019 | -248.00M |
December 31, 2018 | -401.00M |
September 30, 2018 | -494.00M |
June 30, 2018 | -427.00M |
March 31, 2018 | -415.00M |
December 31, 2017 | -592.00M |
Date | Value |
---|---|
September 30, 2017 | -713.00M |
June 30, 2017 | -740.00M |
March 31, 2017 | -936.00M |
December 31, 2016 | -738.00M |
September 30, 2016 | -584.00M |
June 30, 2016 | -603.00M |
March 31, 2016 | -1.271B |
December 31, 2015 | -518.00M |
September 30, 2015 | -577.00M |
June 30, 2015 | -604.00M |
March 31, 2015 | 362.00M |
December 31, 2014 | 86.00M |
September 30, 2014 | 206.00M |
June 30, 2014 | -271.00M |
March 31, 2014 | -537.00M |
December 31, 2013 | -1.106B |
September 30, 2013 | -1.247B |
June 30, 2013 | -950.26M |
March 31, 2013 | -784.53M |
December 31, 2012 | -822.00M |
September 30, 2012 | -846.74M |
June 30, 2012 | -731.54M |
March 31, 2012 | -458.58M |
December 31, 2011 | 64.00M |
September 30, 2011 | 122.98M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.005B
Minimum
Jun 2021
225.00M
Maximum
Dec 2019
-1.131B
Average
-942.00M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
Laboratory Corp of America Holdings | -59.30M |
Exact Sciences Corp | 159.77M |
Delcath Systems Inc | 51.78M |
CytoSorbents Corp | 14.47M |
Progyny Inc | -11.07M |